Skip To Main Content

Artiklar

Sort by

Filtrera

Återställ
  • Filtera
  • Innehållstyp

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy

Recognizing the Urgency to proactively plan a switch: Managing Timely Insulin Transitions for Continuity of Care

Learn why timely insulin transitions are critical for patient safety and continuity of care. Act early to avoid gaps and risks.

Psychological Considerations During Insulin Product Changes

Understanding the psychological burden of switching insulin. Discover ways to cope and support patient well-being during treatment changes.

Diabetes och Ramadan

2026 infaller Ramadan mellan 17 februari och 19 mars. Vi har tagit fram material för att hjälpa dig att stötta din patient med diabetes som vill fasta under Ramadan.

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Defining ITP

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5

Living with ITP

Patients reported significant quality of life (QoL) challenges related to their ITP1

Assessing fatigue in ITP patients

For ITP patients, several scales are available to measure and track fatigue and its impact on quality of life. These tools can help patients and healthcare providers gauge symptoms and adjust their ITP treatment accordingly.1-4

Mechanism of Disease

Complex immune dysregulation can lead to autoimmunity and inflammation1-6